Non-binding Guidance: FDA’s Draft Guidance on Communication of Scientific Information on Unapproved Uses of Medical Products

Lexology November 14, 2023
Ropes & Gray LLP

Click here to listen to the audio.

This installment of Ropes & Gray’s podcast series Non-binding Guidance focuses on FDA’s recently issued draft guidance, “Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products – Questions and Answers.” In this episode, hear from Kellie Combs, Josh Oyster, and Sarah Blankstein, industry-leading attorneys from Ropes & Gray’s life sciences regulatory and compliance team, as they delve into FDA’s new draft guidance to discuss key changes, constitutional considerations, and practical implications for the medical products industry.

Transcript:

Kellie Combs: Hi. I’m Kellie Combs, a partner in the life sciences regulatory and compliance practice at Ropes & Gray. Welcome to Non-binding Guidance, a podcast series from...

Today's Sponsors

Today's Sponsor